Results 191 to 200 of about 41,494 (257)

Lower density of calretinin‐immunopositive neurons in the putamen of subjects with schizophrenia

open access: yesJournal of Anatomy, Volume 246, Issue 4, Page 505-516, April 2025.
Recent neuroimaging and histological studies highlight the striatum as a key area involved in SCH, but the specific impairment of neuronal subtypes in subcortical structures is not fully understood. This study is the first detailed investigation of neuroanatomical changes in the putamen in SCH, specifically examining the density of calretinin ...
Paz Kelmer   +4 more
wiley   +1 more source

Comparative in vitro and in silico evaluation of the toxic effects of metformin and/or ascorbic acid, new treatment options in the treatment of Melasma. [PDF]

open access: yesToxicol Res (Camb)
Yalçın HT   +10 more
europepmc   +1 more source

Neuroprotective effect of cedrol in a male rat model of Parkinson's disease

open access: yesPhysiological Reports, Volume 13, Issue 7, April 2025.
Abstract Cedrol is a natural sesquiterpene subgroup of terpenes with antioxidant and anti‐inflammatory properties. This study evaluated the effect of cedrol on the 6‐hydroxydopamine (6‐OHDA) rat model of Parkinson's disease (PD). Unilateral injection of 6‐OHDA was performed to induce the PD model. Cedrol at 10 mg/kg and 20 mg/kg was administrated.
Fatemeh Forouzanfar   +3 more
wiley   +1 more source

Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment. [PDF]

open access: yesFront Med (Lausanne)
Pistorio S   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy